These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10945850)

  • 21. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effect of trimebutine and N-monodesmethyl trimebutine on trinitrobenzene sulfonic acid-induced colitis in rats.
    Chevalier E; Pétoux F; Chovet M; Langlois A
    Life Sci; 2004 Dec; 76(3):319-29. PubMed ID: 15531383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of TZP-201, a novel motilin receptor antagonist, in the colon of the musk shrew (Suncus murinus).
    Venkova K; Thomas H; Fraser GL; Greenwood-Van Meerveld B
    J Pharm Pharmacol; 2009 Mar; 61(3):367-73. PubMed ID: 19222910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Ca2+-sensitization in attenuated carbachol-induced contraction of the colon in a rat model of colitis.
    Al-Jarallah A; Khan I; Oriowo MA
    Eur J Pharmacol; 2008 Jan; 579(1-3):365-73. PubMed ID: 18037403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
    Ozaki K; Onoma M; Muramatsu H; Sudo H; Yoshida S; Shiokawa R; Yogo K; Kamei K; Cynshi O; Kuromaru O; Peeters TL; Takanashi H
    Eur J Pharmacol; 2009 Aug; 615(1-3):185-92. PubMed ID: 19445919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiological studies of trinitrobenzene sulfonic acid-induced colitis in Syrian hamsters (Mesocricetus auratus).
    Hirota Y; Suzuki M; Yamaguchi K; Fujita T; Katsube N
    Comp Med; 2005 Feb; 55(1):45-54. PubMed ID: 15766209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional difference in the healing process of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats.
    Uchida M; Mogami O; Shimizu K; Matsueda K
    Inflammopharmacology; 2007 Aug; 15(4):158-63. PubMed ID: 17701018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen-activated protein kinase pathways contribute to hypercontractility and increased Ca2+ sensitization in murine experimental colitis.
    Ihara E; Beck PL; Chappellaz M; Wong J; Medlicott SA; MacDonald JA
    Mol Pharmacol; 2009 May; 75(5):1031-41. PubMed ID: 19190174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs.
    Ozaki K; Yogo K; Sudo H; Onoma M; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Pharmacology; 2007; 79(4):223-35. PubMed ID: 17426410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divergent changes to muscarinic and serotonergic signalling following colitis.
    Wells RW; Blennerhassett MG
    Gut; 2005 Dec; 54(12):1699-706. PubMed ID: 16014744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of CPI-17 downregulation in the dysmotility of the colon from dextran sodium sulphate-induced experimental colitis in a mouse model.
    Sato K; Ohkura S; Kitahara Y; Ohama T; Hori M; Sato M; Kobayashi S; Sasaki Y; Hayashi T; Nasu T; Ozaki H
    Neurogastroenterol Motil; 2007 Jun; 19(6):504-14. PubMed ID: 17564632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats.
    Kolgazi M; Jahovic N; Yüksel M; Ercan F; Alican I
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1859-65. PubMed ID: 17914960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological and biochemical characterization of bradykinin B2 receptors in the mouse colon: influence of the TNBS-induced colitis.
    Hara DB; Fernandes ES; Campos MM; Calixto JB
    Regul Pept; 2007 Jun; 141(1-3):25-34. PubMed ID: 17276525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin reduces the expression of chemokines in rat with trinitrobenzene sulfonic acid-induced colitis.
    Li JH; Zhou W; Liu K; Li HX; Wang L
    Saudi Med J; 2008 Aug; 29(8):1088-94. PubMed ID: 18690297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation between 13-Nle-motilin and acetylcholine on rabbit pyloric muscle in vitro.
    Strunz U; Domschke W; Domschke S; Mitznegg P; Wünsch E; Jaeger E; Demling L
    Scand J Gastroenterol Suppl; 1976; 39():29-33. PubMed ID: 1069362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sinomenine attenuates 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice.
    Cheng H; Xia B; Guo Q; Zhang L; Wang F; Jiang L; Wang Z; Zhang Y; Li C
    Int Immunopharmacol; 2007 May; 7(5):604-11. PubMed ID: 17386408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase-dependent alterations in substance P-mediated contractility and tachykinin NK1 receptor expression in the colonic circular muscle of patients with slow transit constipation.
    Liu L; Shang F; Morgan MJ; King DW; Lubowski DZ; Burcher E
    J Pharmacol Exp Ther; 2009 Apr; 329(1):282-9. PubMed ID: 19164461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extrinsic surgical denervation ameliorates TNBS-induced colitis in rats.
    Takami Y; Mantyh CR; Pappas TN; Takahashi T; Koda K; Miyazaki M
    Hepatogastroenterology; 2009; 56(91-92):682-6. PubMed ID: 19621680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical development of recombinant human interleukin 11 (NEUMEGA rhIL-11 growth factor).
    Kaye JA
    Stem Cells; 1996; 14 Suppl 1():256-60. PubMed ID: 11012229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.